Publication | Closed Access

A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors

Solid TumorsMedicinePharmacologyPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyCancer Research